Although autologous stem cell transplant (ASCT) may benefit patients with relapsed or high-risk non-Hodgkin lymphoma (NHL), many patients still relapse and die of their disease. Most relapses occur...
No takes yet. Share an insight, caveat, or question.
Lim et al. (2008) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: